Characterization of a New Chronic Lymphocytic Leukemia Cell Line for Mechanistic In Vitro and In Vivo Studies Relevant to Disease-Reference-Cited by-同舟云学术

Characterization of a New Chronic Lymphocytic Leukemia Cell Line for Mechanistic In Vitro and In Vivo Studies Relevant to Disease

Published:2013-10-09 Issue:10 Volume:8 Page:e76607
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hertlein Erin,Beckwith Kyle A.,Lozanski Gerard,Chen Timothy L.,Towns William H.,Johnson Amy J.,Lehman Amy,Ruppert Amy S.,Bolon Brad,Andritsos Leslie,Lozanski Arletta,Rassenti Laura,Zhao Weiqiang,Jarvinen Tiina M.,Senter Leigha,Croce Carlo M.,Symer David E.,de la Chapelle Albert,Heerema Nyla A.,Byrd John C.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference47 articles.

1. Clonal evolution in chronic lymphocytic leukemia studied by interphase fluorescence in-situ hybridization;A Berkova;Neoplasma,2009

2. Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients;F Cavazzini;Leuk Lymphoma,2012

3. High-risk clonal evolution in chronic B-lymphocytic leukemia: single-center interphase fluorescence in situ hybridization study and review of the literature;A Janssens;Eur J Haematol,2012

4. Clonal evolution in patients with chronic lymphocytic leukemia;J Loscertales;Leuk Lymphoma,2010

5. Karyotype evolution on fluorescent in situ hybridization analysis is associated with short survival in patients with chronic lymphocytic leukemia and is related to CD49d expression;TD Shanafelt;J Clin Oncol,2008

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD38 regulates chronic lymphocytic leukemia proliferation via CD45 phosphatase activity;Molecular Therapy: Oncology;2024-09

2. The Novel Anti-Cancer Agent, SpiD3, Is Cytotoxic in CLL Cells Resistant to Ibrutinib or Venetoclax;Hemato;2024-08-27

3. Potential impact of NOTCH1 activation on venetoclax sensitivity in chronic lymphocytic Leukaemia: In vitro insights and clinical implications;British Journal of Haematology;2024-06-21

4. Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects;Cancer Research Communications;2024-05-22

5. Novel spirocyclic dimer, SpiD3, targets chronic lymphocytic leukemia survival pathways with potent preclinical effects;2024-02-03